Effect of small doses of naloxone on sexual exhaustion in White New Zealand male rabbits

Study of copulatory behaviour in old male rabbits

<p>Male rabbit sexual behaviour consists of a single mount followed immediately by ejaculation. In young bucks this pattern changes gradually as they reach sexual satiety in a day and sexual exhaustion after several daily tests. Little is known about the characteristics of sexual behaviour in old rabbits (aged 48-54 mo) within a day and across daily tests leading to sexual exhaustion. By using sexually receptive(young) females, changed within a session to maximise copulation, we found that: a) the inter-ejaculatory interval increased between the first and last days of testing; b) test duration was 3.1 h on day 1 and 0.5 h on day 15; c) the “miss rate” (i.e., mounts not accompanied by ejaculation) significantly increased from the first to the last day of testing, regardless of when this occurred in each individual buck; d) the total number of ejaculations displayed in a session significantly decreased between the first and the last day of testing in all males; e) scent-marking (“chinning”) frequency significantly decreased after copulation to satiety, relative to that quantified at baseline, and was restored the following day. Compared with young bucks our results indicate quantitative, rather than qualitative, differences in sexual behaviour associated with age in rabbits. Specifically, on day 1 old bucks spent a shorter time engaged in copulation and displayed a lower number of ejaculations before reaching satiety than young males. In contrast, the interval between ejaculatory events and the “miss rate” increased across test days in both old and young rabbits. These results merit investigating the neuroendocrine mechanisms underlying the display of such an active sexual behaviour by old rabbit bucks.</p>

Mu opioid receptor in spermatozoa, eggs and larvae of gilthead sea bream (Sparus Aurata) and its involvement in stress related to aquaculture

In aquaculture, unfavourable conditions experienced during early development may have strong downstream effects on the adult phenotype and fitness. Sensitivity to stress, leading to disease, reduced growth and mortality, is higher in larvae than in adult fish. In this study, conducted on sea bream (Sparus aurata), we evidenced the presence of the mu opioid receptor in gametes and larvae at different developmental stages. Moreover, we evaluated the possibility of reducing the effects of artificially produced stress, altering temperature, salinity and pH, by naloxone (an opioid antagonist) and calcium. Results evidenced that mu opioid receptor is present in larvae and in gametes of both sexes and that, during larval growth, its expression level changes accordingly; furthermore, naloxone/calcium association is efficacious in increasing the survival period of treated larvae compared to controls. We conclude that in sea bream rearing, the use of naloxone/calcium against stress can improve fish farming techniques by reducing larval mortality and consequently increasing productivity.

Endogenous opiates and behavior: 2005

This paper is the 28th consecutive installment of the annual review of research concerning the endogenous opioid system, now spanning over a quarter-century of research. It summarizes papers published during 2005 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior (Section 2), and the roles of these opioid peptides and receptors in pain and analgesia (Section 3); stress and social status (Section 4); tolerance and dependence (Section 5); learning and memory (Section 6); eating and drinking (Section 7); alcohol and drugs of abuse (Section 8); sexual activity and hormones, pregnancy, development and endocrinology (Section 9); mental illness and mood (Section 10); seizures and neurologic disorders (Section 11); electrical-related activity, neurophysiology and transmitter release (Section 12); general activity and locomotion (Section 13); gastrointestinal, renal and hepatic functions (Section 14); cardiovascular responses (Section 15); respiration and thermoregulation (Section 16); immunological responses (Section 17).